BioMarin rare disease biologic meets only 1 of 2 endpoints in phase 3 trial
BioMarin Pharmaceuticals Inc · PHARMACEUTICAL PREPARATIONS · Now $57.29
+8.9% in 3d after detection
Post-detection moves
1h
—
1d
+0.3%
3d
+8.9%
7d
+6.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS